Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.

Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.

The most relevant endpoint in therapeutic HIV vaccination is the assessment of time to viral rebound or duration of sustained control of low-level viremia upon cART treatment cessation. Structured treatment interruptions (STI) are however not without risk to the patient and reliable predictors of vi...

Full description

Bibliographic Details
Main Authors: Miriam Rosás-Umbert, Beatriz Mothe, Marc Noguera-Julian, Rocío Bellido, Maria C Puertas, Jorge Carrillo, C Rodriguez, Núria Perez-Alvarez, Patricia Cobarsí, Carmen E Gomez, Mariano Esteban, Jose Luis Jímenez, Felipe García, Julià Blanco, Javier Martinez-Picado, Roger Paredes, Christian Brander
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5617163?pdf=render

Internet

http://europepmc.org/articles/PMC5617163?pdf=render

Similar Items